{"id":"W2149095868","doi":"10.1200/jco.2008.18.4408","title":"Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute","keywords":"Gefitinib; Medicine; Placebo; Internal medicine; Lung cancer; Hazard ratio; Performance status; Clinical endpoint; Chemotherapy; Population; Adverse effect; Oncology; Gastroenterology; Cancer; Randomized controlled trial; Epidermal growth factor receptor; Pathology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006435749,0.0001572275,0.001821427,0.0001183438,0.00004422091,0.000004102969,0.00006033603,0.00008708637,0.00002922175],"category_scores_gemma":[0.0001158851,0.00008724679,0.00008882543,0.0001405306,0.0001240095,0.0001083026,0.00001120042,0.0003828961,1.462074e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001507977,"about_ca_system_score_gemma":0.001089822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005819415,"about_ca_topic_score_gemma":0.0001067416,"domain_scores_codex":[0.9978361,0.0001568458,0.001366333,0.0001766675,0.000258571,0.0002054543],"domain_scores_gemma":[0.9971585,0.000573584,0.001501481,0.000107386,0.0004454609,0.0002135561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5406404,0.01643441,0.372409,0.00003630466,0.0007091779,0.00006545591,0.00280591,0.0003453835,0.00001796186,9.167978e-7,0.00005714573,0.06647788],"study_design_scores_gemma":[0.6344917,0.06243427,0.3005382,0.000216883,0.0009896151,0.000007893718,0.0005859099,0.0004469505,0.0000329112,0.000002133239,0.0001825858,0.00007093917],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963565,0.0003686807,0.0000312209,0.0006836687,0.0001114674,0.001782611,0.000007120671,0.000003876411,0.0006548563],"genre_scores_gemma":[0.9963315,0.0007671124,0.002013481,0.0006730714,0.00007377133,0.00003260779,0.000004915867,0.00001244478,0.00009108449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09385128,"threshold_uncertainty_score":0.3557821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03107094173745758,"score_gpt":0.4432891018328478,"score_spread":0.4122181600953903,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}